ArticleHuman vaccines & immunotherapeutics2022

Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany.

Daniel Molnar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.